Indication
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy is an inherited cardiovascular disorder most commonly caused by autosomal-dominant mutations in cardiac sarcomere protein genes. Read more about Hypertrophic cardiomyopathy
69 drugs 53 manufacturers
Drugs that treat it
Common Hypertrophic cardiomyopathy therapies.
ABLYSINOL (ethyl alcohol)
PROPRANOLOL (propranolol HCl)
PROPRANOLOL HCL
PROPRANOLOL HCL ER (propranolol HCl)
PROPRANOLOL HCL
PROPRANOLOL HCL ER (propranolol HCl)
PROPRANOLOL HCL
PROPRANOLOL HCL ER (propranolol HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHypertrophic cardiomyopathy is an inherited cardiovascular disorder most commonly caused by autosomal-dominant mutations in cardiac sarcomere protein genes.
It is clinically defined by unexplained left ventricular hypertrophy—frequently involving asymmetric septal thickening—and cellular myocyte disarray in the absence of another systemic or cardiac condition capable of producing a similar magnitude of hypertrophy.
The pathophysiology is characterized by impaired diastolic filling, myocardial ischemia, and, in a significant subset of patients, dynamic left ventricular outflow tract obstruction that is often exacerbated by systolic anterior motion of the mitral valve.
Manifestations range from asymptomatic courses to exertional dyspnea, chest pain, syncope, heart failure, and life-threatening ventricular arrhythmias or sudden cardiac death.
- nih.gov
Hypertrophic cardiomyopathy is an inherited cardiovascular disorder most commonly caused by autosomal-dominant mutations in cardiac sarcomere protein genes It is clinically defined by unexplained left ventricular hypertrophy—frequently involving asymmetric septal thickening—and cellular myocyte disarray in the absence of another systemic or cardiac condition capable of producing a similar magnitude of hypertrophy The pathophysiology is characterized by impaired diastolic filling, myocardial isch...
- nih.gov
Hypertrophic cardiomyopathy is an inherited cardiovascular disorder most commonly caused by autosomal-dominant mutations in cardiac sarcomere protein genes
- nih.gov
It is clinically defined by unexplained left ventricular hypertrophy—frequently involving asymmetric septal thickening—and cellular myocyte disarray in the absence of another systemic or cardiac condition capable of producing a similar magnitude of hypertrophy
- youtube.com
The pathophysiology is characterized by impaired diastolic filling, myocardial ischemia, and, in a significant subset of patients, dynamic left ventricular outflow tract obstruction that is often exacerbated by systolic anterior motion of the mitral valve
Personalize your experience
Follow Hypertrophic cardiomyopathy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.